Bristol-Myers Squibb Company has 39 disclosed EU lobbying meetings from 2024-07-19 to 2026-06-03: 11 with the European Commission and 28 with Members of the European Parliament. Source: EU Transparency Register no. 04437556781-76, Commission disclosures and MEP declarations. Methodology
Bristol-Myers Squibb Company
EU lobbying footprint — who they meet, and on what.
- Register no.
- 04437556781-76 ↗
- Disclosed meetings
- 39 (11 Commission · 28 MEP)
- Period
- 2024-07-19 → 2026-06-03
Declared fields of interest: Banking and financial services · Budget · Business and industry · Competition · Consumers · Customs · Digital economy and society · Economy, finance and the euro · Employment and social affairs · Environment · External relations · Institutional affairs
Lobbying profile
as declared 2026-03-05- Category
- Companies & groups
- Legal status
- Corporation
- Declared lobbying cost
- €2,500,000
- Lobbying FTEs
- 3.95
- Members
- 3
At a glance
- Technology6
- Health2
- Rainer Becker3
- Laszlo Kristoffy2
- Patricia Reilly2
- Chiara Galiffa1
- Ann-Sofie Ronnlund1
Disclosed meetings
Newest first. EC = European Commission, EP = Member of the European Parliament.
- Biotech Act Isource ↗
- 2026-05-07ECChiara Galiffa · Cabinet of Commissioner Maroš ŠefčovičLatest developments in EU-US relationssource ↗
- 2026-05-07ECLaszlo Kristoffy · Cabinet of Commissioner Olivér VárhelyiRoundtable on the health packagesource ↗
- Health Policysource ↗
- Biotech Actsource ↗
- Biotech actsource ↗
- Biotech Act Isource ↗
- 2026-04-01ECRainer Becker · DirectorExchange of views on the Biotech Act and on the international pharmaceutical situationsource ↗
- Biotech Actsource ↗
- 2026-03-24ECPatricia Reilly · Cabinet of President Ursula von der LeyenExchange on Biotech Act and strategic policy issuessource ↗
- 2026-03-24ECAnn-Sofie Ronnlund · Cabinet of Commissioner Ekaterina ZaharievaLife sciencessource ↗
- 2026-03-20ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiLeiden Car-T site visitsource ↗
- Biotech actsource ↗
- 2026-01-22ECLaszlo Kristoffy · Cabinet of Commissioner Olivér VárhelyiHealth Package – Biotech Actsource ↗
- 2025-12-05ECRainer Becker · DirectorThe aim of the meeting was to discuss the possible improvements to the Clinical Trials Regulation, IP frameworks and cell therapy in the Biotech Actsource ↗
- Meetingsource ↗
- 2025-11-18ECPatricia Reilly · Cabinet of President Ursula von der LeyenBiotechnology actssource ↗
- CMAsource ↗
- 2025-09-30ECGiulia Del Brenna · Head of UnitIssues and concerns related to the EU’s competitiveness in this sector, in particular regarding European legislation, U.S. tariffs on pharmaceuticals, and intellectual property.source ↗
- Exchange of viewssource ↗
- European Medicinesource ↗
- 2025-09-17ECRainer Becker · DirectorExchange on clinical trials in the context of the upcoming proposal for an EU Biotech Actsource ↗
- Critical Medicines Act and procurementsource ↗
- The Critical Medicines Act: Opportunities Aheadsource ↗
- Critical Medicines Actsource ↗
- Critical Medicines Actsource ↗
- Critical Medicines Actsource ↗
- Introduction, exchange of views on pharmaceutical legislationsource ↗
- pharma industry in the EUsource ↗
- Healthsource ↗
- Health Policysource ↗
- The Future of Clinical Trials and the EU Life Sciences Strategysource ↗
- Biotech sector in the EUsource ↗
- The discussion with General Manager for Central and Eastern Europe about the vision for improving the EU’s competitiveness in the life sciences sectorsource ↗
- Regulation of pahrmaceuticalssource ↗
- Introductory Meetingsource ↗
- European Health policysource ↗
- Health policysource ↗
- European industrial policysource ↗
Lobbying in these areas
Frequently asked
How many EU lobbying meetings has Bristol-Myers Squibb Company disclosed?
Bristol-Myers Squibb Company (EU Transparency Register no. 04437556781-76) appears in 39 disclosed meetings with EU officials and MEPs between 2024-07-19 and 2026-06-03: 11 with the European Commission and 28 with Members of the European Parliament.
What does Bristol-Myers Squibb Company lobby on?
Bristol-Myers Squibb Company's disclosed EU meetings most often concern Technology, Health. Every meeting and its topic is listed with its official source on this page.
Who does Bristol-Myers Squibb Company meet in Brussels?
Across its disclosed meetings, Bristol-Myers Squibb Company has met Commission officials including Rainer Becker, Laszlo Kristoffy, Patricia Reilly, and MEPs including ANDRIUKAITIS Vytenis Povilas, SOKOL Tomislav, WÖLKEN Tiemo. These are counts of officially disclosed meetings, not a measure of influence.
Primary sources
- EU Transparency Register profile (no. 04437556781-76) ↗
- European Commission meeting disclosures ↗
- European Parliament — MEP meeting declarations ↗
Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.
Get the EU lobbying brief
We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.